vs

Side-by-side financial comparison of PROGRESS SOFTWARE CORP (PRGS) and Ultragenyx Pharmaceutical Inc. (RARE). Click either name above to swap in a different company.

PROGRESS SOFTWARE CORP is the larger business by last-quarter revenue ($252.7M vs $207.3M, roughly 1.2× Ultragenyx Pharmaceutical Inc.). PROGRESS SOFTWARE CORP runs the higher net margin — 10.2% vs -62.0%, a 72.2% gap on every dollar of revenue. On growth, Ultragenyx Pharmaceutical Inc. posted the faster year-over-year revenue change (25.9% vs 17.5%). PROGRESS SOFTWARE CORP produced more free cash flow last quarter ($59.9M vs $-100.8M). Over the past eight quarters, Ultragenyx Pharmaceutical Inc.'s revenue compounded faster (38.0% CAGR vs 17.0%).

Progress Software Corporation develops and sells enterprise software products including application development platforms, data connectivity tools, and digital experience solutions. It serves global enterprise clients across finance, healthcare, manufacturing, retail and other sectors, helping organizations build scalable, high-performance business applications and streamline operational workflows.

Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic diseases for which there are typically no approved treatments and high unmet medical need. The company works with multiple drug modalities including biologics, small molecule, gene therapies, and ASO and mRNAs in the disease categories of bone, endocrine, metabolic, muscle and CNS diseases.

PRGS vs RARE — Head-to-Head

Bigger by revenue
PRGS
PRGS
1.2× larger
PRGS
$252.7M
$207.3M
RARE
Growing faster (revenue YoY)
RARE
RARE
+8.4% gap
RARE
25.9%
17.5%
PRGS
Higher net margin
PRGS
PRGS
72.2% more per $
PRGS
10.2%
-62.0%
RARE
More free cash flow
PRGS
PRGS
$160.7M more FCF
PRGS
$59.9M
$-100.8M
RARE
Faster 2-yr revenue CAGR
RARE
RARE
Annualised
RARE
38.0%
17.0%
PRGS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PRGS
PRGS
RARE
RARE
Revenue
$252.7M
$207.3M
Net Profit
$25.7M
$-128.6M
Gross Margin
81.6%
Operating Margin
15.2%
-54.7%
Net Margin
10.2%
-62.0%
Revenue YoY
17.5%
25.9%
Net Profit YoY
2144.6%
3.5%
EPS (diluted)
$0.59
$-1.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRGS
PRGS
RARE
RARE
Q4 25
$252.7M
$207.3M
Q3 25
$249.8M
$159.9M
Q2 25
$237.4M
$166.5M
Q1 25
$238.0M
$139.3M
Q4 24
$215.0M
$164.6M
Q3 24
$178.7M
$139.5M
Q2 24
$175.1M
$147.0M
Q1 24
$184.7M
$108.8M
Net Profit
PRGS
PRGS
RARE
RARE
Q4 25
$25.7M
$-128.6M
Q3 25
$19.4M
$-180.4M
Q2 25
$17.0M
$-115.0M
Q1 25
$10.9M
$-151.1M
Q4 24
$1.1M
$-133.2M
Q3 24
$28.5M
$-133.5M
Q2 24
$16.2M
$-131.6M
Q1 24
$22.6M
$-170.7M
Gross Margin
PRGS
PRGS
RARE
RARE
Q4 25
81.6%
Q3 25
81.0%
Q2 25
80.1%
Q1 25
80.6%
Q4 24
83.0%
Q3 24
83.7%
Q2 24
81.7%
Q1 24
82.2%
Operating Margin
PRGS
PRGS
RARE
RARE
Q4 25
15.2%
-54.7%
Q3 25
17.6%
-106.9%
Q2 25
16.3%
-64.8%
Q1 25
13.6%
-102.6%
Q4 24
10.0%
-74.3%
Q3 24
22.6%
-94.6%
Q2 24
15.5%
-79.1%
Q1 24
19.0%
-151.9%
Net Margin
PRGS
PRGS
RARE
RARE
Q4 25
10.2%
-62.0%
Q3 25
7.8%
-112.8%
Q2 25
7.2%
-69.0%
Q1 25
4.6%
-108.5%
Q4 24
0.5%
-80.9%
Q3 24
15.9%
-95.7%
Q2 24
9.2%
-89.5%
Q1 24
12.3%
-156.8%
EPS (diluted)
PRGS
PRGS
RARE
RARE
Q4 25
$0.59
$-1.28
Q3 25
$0.44
$-1.81
Q2 25
$0.39
$-1.17
Q1 25
$0.24
$-1.57
Q4 24
$0.01
$-1.34
Q3 24
$0.65
$-1.40
Q2 24
$0.37
$-1.52
Q1 24
$0.51
$-2.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRGS
PRGS
RARE
RARE
Cash + ST InvestmentsLiquidity on hand
$94.8M
$421.0M
Total DebtLower is stronger
$1.4B
Stockholders' EquityBook value
$478.3M
$-80.0M
Total Assets
$2.5B
$1.5B
Debt / EquityLower = less leverage
2.93×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRGS
PRGS
RARE
RARE
Q4 25
$94.8M
$421.0M
Q3 25
$99.0M
$202.5M
Q2 25
$102.0M
$176.3M
Q1 25
$124.2M
$127.1M
Q4 24
$118.1M
$174.0M
Q3 24
$232.7M
$150.6M
Q2 24
$190.4M
$480.7M
Q1 24
$133.2M
$112.3M
Total Debt
PRGS
PRGS
RARE
RARE
Q4 25
$1.4B
Q3 25
$1.4B
Q2 25
$1.5B
Q1 25
$1.5B
Q4 24
$1.5B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
PRGS
PRGS
RARE
RARE
Q4 25
$478.3M
$-80.0M
Q3 25
$477.7M
$9.2M
Q2 25
$452.7M
$151.3M
Q1 25
$431.8M
$144.2M
Q4 24
$438.8M
$255.0M
Q3 24
$425.6M
$346.8M
Q2 24
$401.7M
$432.4M
Q1 24
$461.7M
$140.3M
Total Assets
PRGS
PRGS
RARE
RARE
Q4 25
$2.5B
$1.5B
Q3 25
$2.4B
$1.2B
Q2 25
$2.4B
$1.3B
Q1 25
$2.5B
$1.3B
Q4 24
$2.5B
$1.5B
Q3 24
$1.6B
$1.5B
Q2 24
$1.6B
$1.6B
Q1 24
$1.5B
$1.3B
Debt / Equity
PRGS
PRGS
RARE
RARE
Q4 25
2.93×
Q3 25
2.97×
Q2 25
3.22×
Q1 25
3.50×
Q4 24
3.48×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRGS
PRGS
RARE
RARE
Operating Cash FlowLast quarter
$62.8M
$-99.8M
Free Cash FlowOCF − Capex
$59.9M
$-100.8M
FCF MarginFCF / Revenue
23.7%
-48.6%
Capex IntensityCapex / Revenue
1.1%
0.5%
Cash ConversionOCF / Net Profit
2.44×
TTM Free Cash FlowTrailing 4 quarters
$229.5M
$-472.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRGS
PRGS
RARE
RARE
Q4 25
$62.8M
$-99.8M
Q3 25
$73.4M
$-91.4M
Q2 25
$30.0M
$-108.3M
Q1 25
$68.9M
$-166.5M
Q4 24
$19.7M
$-79.3M
Q3 24
$57.7M
$-67.0M
Q2 24
$63.7M
$-77.0M
Q1 24
$70.5M
$-190.7M
Free Cash Flow
PRGS
PRGS
RARE
RARE
Q4 25
$59.9M
$-100.8M
Q3 25
$72.4M
$-92.7M
Q2 25
$29.5M
$-110.7M
Q1 25
$67.7M
$-167.8M
Q4 24
$16.8M
$-79.5M
Q3 24
$56.6M
$-68.6M
Q2 24
$62.7M
$-79.0M
Q1 24
$70.2M
$-193.9M
FCF Margin
PRGS
PRGS
RARE
RARE
Q4 25
23.7%
-48.6%
Q3 25
29.0%
-58.0%
Q2 25
12.4%
-66.5%
Q1 25
28.4%
-120.5%
Q4 24
7.8%
-48.3%
Q3 24
31.7%
-49.2%
Q2 24
35.8%
-53.7%
Q1 24
38.0%
-178.2%
Capex Intensity
PRGS
PRGS
RARE
RARE
Q4 25
1.1%
0.5%
Q3 25
0.4%
0.8%
Q2 25
0.2%
1.5%
Q1 25
0.5%
1.0%
Q4 24
1.3%
0.1%
Q3 24
0.6%
1.2%
Q2 24
0.5%
1.4%
Q1 24
0.2%
3.0%
Cash Conversion
PRGS
PRGS
RARE
RARE
Q4 25
2.44×
Q3 25
3.78×
Q2 25
1.76×
Q1 25
6.30×
Q4 24
17.13×
Q3 24
2.03×
Q2 24
3.93×
Q1 24
3.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRGS
PRGS

Maintenanceand Services$187.5M74%
Share File Acquisition$67.5M27%

RARE
RARE

Royalty$105.6M51%
Products$101.7M49%

Related Comparisons